Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Walgreens Halts Boots Sale, Citing Market Uncertainty

Published 28/06/2022, 15:00
Updated 28/06/2022, 15:00
© Reuters

© Reuters

By Scott Kanowsky 

Investing.com -- U.S.-listed shares in Walgreens Boots Alliance Inc (NASDAQ:WBA) edged slightly higher in early U.S. trading on Tuesday, after the drug store group announced that it would not be selling its Boots division.

In a statement, the group said it held "productive discussions" with suitors for the U.K. pharmacy chain and its cosmetics business No7 Beauty Company, but decided to ditch the sales due to uncertainty in global markets.

"As a result of market instability severely impacting financing availability, no third party has been able to make an offer that adequately reflects the high potential value of Boots and No7 Beauty Company," Walgreens said. "Consequently, WBA has decided that it is in the best interests of shareholders to keep focusing on the further growth and profitability of the two businesses."

Walgreens chief executive Rosalind Brewer said both Boots and No7 Beauty still hold "strong fundamental value," adding that the group will remain open to opportunities to "maximize shareholder value" for the companies.

Media reports had suggested that the only bid offered for Boots came from a consortium of private equity firm Apollo Management and Reliance Industries, a conglomerate owned by Indian industrialist and billionaire Mukesh Ambani. According to the Financial Times, the proposal had valued Boots at between £5B - £6B, and allowed Walgreens to maintain a minority stake.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.